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We thank the reviewers for their input and helpful comments. We have addressed their 
specific points as follows: 
 
Reviewer #1:  
 
p3, l51-54: Like the protein, the function appears evolutionary conserved, as similar 
phenotyes were observed in ciliates by El-Haddad, H. et al. (2013; Characterization of 
TtALV2, an essential charged repeat motif protein of the Tetrahymena thermophila 
membrane skeleton. Eukaryotic Cell 12, 932-940). Worth mentioning, also because in the 
ciliate it was not a KO, but a downregulation, too (dose-dependent) and hence similar to what 
the authors describe for the mutants e.g. on p12 middle section. 
To reflect the reviewer's point, we have added the sentence: "In Tetrahymena thermophila, 
knockdown of the alveolin TtALV2 was also reported to affect cell morphology in (El-
Haddad et al., 2013)), indicating that alveolin functions, like their structures, are evolutionary 
conserved." (lines 51-53). 
 
p4, l62: The authors draw a connection between the alveolins and intermediate filaments 
based on the repeat motifs. Such a comparsion was already explicitly drawn by El-Haddad et 
al. 2013 and and should mentioned accordingly. 
We have added the El-Haddad et al (2013) reference to reflect this (line 58). 
 
p4, l68-70: The CC-motifs have not only been implied in S-palmitoylation. Note: "This CC 
motif is present in both termini of PfALV1 and TgALV1 but only at the N-terminus of 
PfALV4, TgALV4, and TpALV2 (fig. 1, arrows). We have not identified a CC motif within 
dinoflagellate or ciliate alveolins, perhaps suggesting that the motif has a role in either the 
unique motility of apicomplexa or their unusual modes of cytokinesis." It's from Gould et al. 
2008 that you cite, so please mention this. 
To reflect the reviewer's point, we have added the sentence: "Because these conserved 
cysteine motifs have not been identified in alveolins from dinoflagellates or ciliates, their 
function could be related to the unique motility and/or cytokinesis associated with the 
Apicomplexa (Gould et al., 2008)." (69-71). 
 
p15, l330-331: on the formation of disulfide bonds and the unfavorable conditions. Correct, 
and which is why it happens in the IMS of mitochondria and the ER only. This could use a 
citation and Herrmann and Riemer 2014 might be a good choice (2014; Three Approaches to 
One Problem: Protein Folding in the Periplasm, the Endoplasmic Reticulum, and the 
Intermembrane Space. Antioxid. Redox Signal. 21, 438-456). 
We have now added this citation. 
 
p18, 402-412. How sure can we be that the single C residue of the carboxy terminus plays no 
role in processing as it does in Toxoplasma (Mann et al. 2002)? A transgenic line was 
generated that expresses a full-length version of IMC1a with a C-terminal mCherry tag for the 
analysis. Could that not influence the ability of the protease to reach the cleavage motif? 
What is known for other Plasmodium spec.? 
To address the reviewer's comment we have added the following to the relevant part of the 
Discussion section: "It cannot be ruled out that the mCherry tag stopped the protease 
responsible from reaching the C-terminal cleavage site, preventing the IMC1a cleavage in our 
parasite lines. Arguing against this possibility, however, is the fact that mCherry tagging of 
IMC1a did not affect its subcellular localisation or cause a detectable phenotype, which 
indicates that IMC1a function was not affected." (lines 414-418). It is currently not known 
what the situation is for other Plasmodium species. 
 
The authors show a post-transcriptional effect on the quantity of IMC1a when the CC motifs 
are manipulated. The authors discuss the phenotypes, etc. but a bit more reasoning on how 
and at what point the authors think the levels of protein are reduced would be nice. Is less 
*Response to Reviewers
protein translated? Seems unlikely, right? The folding (C-C bridges) is unlikely as the authors 
correctly mention, but can there be no alternative to palmitoylation? See also previous point. 
To address the reviewer's comments have added the following sentence to the Discussion 
section: "We did not observe sporozoites with high (WT) levels of fluorescence in our mutant 
sporozoite populations. Assuming that IMC1a expression was not affected by the cysteine 
mutations, this suggests that the reductions in IMC1a levels occurred soon after translation 
and possibly before IMC1a recruitment to the pellicle". (lines 330-333). 
 
 
Reviewer #2:  
 
Specific comments 
The findings in this manuscript are interesting, specifically the fact that only the deletion of 
the N-terminal cysteines of IMC1a seem to affect salivary gland invasion more than C-
terminal ones. Could it be that they play a regulatory role and apart from their suggested role 
in Palmitoylation? Alternatively are they involved in other palmitoylation dependent cellular 
functions apart from structural re-enforcement? 
To reflect the reviewer's point, we have added the following to the Discussion section: 
"Mutation of the N-terminal cysteine motif of IMC1a (Mutant 1) causes more severe 
phenotypes than substitution of the C-terminal cysteine motif (Mutant 2) with regards to 
IMC1a stability (Fig. 3A) and infectivity to the salivary glands (Table 1). This difference 
could reflect quantitative differences in palmitoylation at the N- and C-terminus, as predicted 
(Fig. 1). Alternatively, the cysteine motifs may possess additional roles besides acting as 
palmitoylation sites, which could be different between the N- and C-terminus." (lines 398-
403). 
 
In the Graphical abstract the bulging portion of the sporozoite seems to be slightly different 
between the three parasite lines. Is this representative of all the sporozoites in the mutant 
population?  
The images shown in the graphical abstract are typical, but the position of the bulging area in 
the mutant sporozoites can be located anywhere between one end and the middle of the 
sporozoite, as reported previously for IMC1a knockout sporozoites (Khater et al., 2004).  
 
Apart from IMC1 do the other Toxoplasma homologues of the alveolins have the cysteine  
residues conserved? Would it be worthwhile showing this in figure 1? This (Foe et al., Cell 
host microbe 2015) may be a valuable reference on the global Palmitome in Toxoplasma. 
A subset of Toxoplasma alveolins possess similar conserved terminal cysteine motifs (IMC1, 
IMC4, IMC14 and IMC15) (Anderson-white et al., 2011) and this has now been added to the 
Introduction (lines 67-69) rather than to Fig. 1. Of these, IMC1, IMC4 and IMC14, but not 
IMC15 are shown to be palmitoylated in tachyzoites (Foe et al., 2015). 
 
Line 210: The sentence belongs in the methods section. 
This sentence has now been moved to section 2.4 of the Materials and Methods (lines 153-
154). 
 
Line 236: The fluorescent levels as shown by Fig. 2 are better shown as black and white 
images and ideally should be quantified. 
As requested we are now showing Fig. 2 (and Fig. 4) in black and white. The IMC1a levels 
were quantified by western blot and the values stated in the text (line 242). This is a much 
better way than quantifying the fluorescence of individual oocysts, as the values obtained 
reflect the entire sporozoite population and can be normalized. 
 
Line 275: It would be nice to show representative images of midgut sporozoites in the 
supplement to validate this statement.  
As requested we have added a supplemental Fig. S2 showing representative images of midgut 
sporozoites of WT, Mutant 1 and Mutant 2.  
 
Line 280-293: How does the sporozoite infectivity reduction observed in mosquitoes relate to 
transmission to the rodent? Data should be shown if just numbers of infected mice per total 
mice challenged. Considering that mutants 1,2, all have intermediate phenotypes compared to 
the knockout it would be sensible to suggest that transmission into mice would also be 
partially rescued? 
To address the reviewer's point we have added the following to the Results section: "The lack 
of mosquito transmission of Mutant 1 could be caused by the low numbers of salivary gland 
sporozoites, or by a reduced sporozoite infectivity to the mouse, or a combination of both. 
Because of the low numbers of salivary gland sporozoites that could be obtained from Mutant 
1-infected mosquitoes, sporozoite infectivity to the mouse by needle injection was not 
assessed." (lines 290-294). Nonetheless, the results (Table 1) clearly show that Mutant 1 and 
Mutant 2 possess intermediate phenotypes with regards to sporozoite infectivity. 
 
Line 290-293: Was there an attempt to also try and transmit the mutant 1 parasites 
intravenously?  
No, see previous point. 
 
Line 301: What would happen if all the cysteines were deleted i.e both the N and C terminal 
ones? It's not necessary to do the experiment but please speculate.  
A 'double' mutant would likely result in even greater protein instability and reductions in 
IMC1a levels than the single mutations, and hence a phenotype more similar to the knockout.  
 
Line 316:  There is no data to back this claim.  
We have removed this sentence. 
 
Line 456 and 458: The references are not consistent with the rest (journal name).  
We have corrected the references’ format. 
 
Table 1: please report meaningful numbers, 10,938 is not a sensible number, make it 11.000 
and adjust similarly all the other figures in the table.  
As requested we have now rounded the numbers in the table. 
 
Put scale bars on all figures with images. 
Scale bars have now been added to Figs. 2 and 4. 
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Abstract 19 
Apicomplexan parasites possess a unique cortical cytoskeleton structure composed of intermediate 20 
filaments. Its building blocks are provided by a conserved family of proteins named alveolins. The core 21 
alveolin structure is made up of tandem repeat sequences, thought to be responsible for the filamentous 22 
properties of these proteins. A subset of alveolins also possess conserved motifs composed of three closely 23 
spaced cysteine residues situated near the ends of the polypeptides. The roles of these cysteine motifs and 24 
their contribution to alveolin function remains poorly understood. The sporozoite-expressed IMC1a is 25 
unique within the Plasmodium alveolin family in having conserved cysteine motifs at both termini. Using 26 
transgenic Plasmodium berghei parasites, we show in this structure-function analysis that mutagenesis of 27 
the amino- or carboxy-terminal cysteine motif causes marked reductions in IMC1a protein levels in the 28 
parasite, which are accompanied by partial losses of sporozoite shape and infectivity. Our findings give 29 
new insight into alveolin function, identifying a dose-dependent effect of alveolin depletion on sporozoite 30 
size and infectivity, and vital roles of the terminal cysteine motifs in maintaining alveolin stability in the 31 
parasite. 32 
 33 
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1. Introduction 35 
Plasmodium species, the causative agents of malaria, have a complex life cycle in vertebrate host and 36 
mosquito vector. Among the many different developmental forms of the parasite feature three motile and 37 
invasive stages (also known as 'zoites'): the ookinete, sporozoite and merozoite. The zoites of Plasmodium, 38 
as well as those of related apicomplexan parasites, possess an unusual cortical structure termed the pellicle. 39 
The pellicle is defined by a double membrane structure termed the inner membrane complex (IMC) situated 40 
directly underneath the plasma membrane, which is equivalent to a system of flattened sacs or alveoli [1-3]. 41 
On the cytoplasmic face of the IMC is anchored a network of intermediate filaments termed the 42 
subpellicular network (SPN), the function of which is to support the pellicle membranes and give the cell 43 
mechanical strength [4].  44 
 A family of proteins now termed alveolins have been identified as components of the SPN [4, 5]. 45 
The alveolin superfamily includes structurally related proteins from apicomplexan parasites, ciliates and 46 
dinoflagellate algae, the three phyla comprising the Alveolata superphylum [6]. In the genus Plasmodium, 47 
13 conserved and syntenic alveolin family members have been identified that are differentially expressed 48 
among the three different zoites stages of malaria parasites [7, 8]. It has been shown in the rodent malaria 49 
species P. berghei that disruption of alveolins gives rise to morphological aberrations that are accompanied 50 
by reduced tensile strength of the zoite stages in which they are found [5, 8-11]. In Tetrahymena 51 
thermophila, knockdown of the alveolin TtALV2 was also reported to affect cell morphology [12], 52 
indicating that alveolin functions, like their structures, are evolutionary conserved. Plasmodium alveolins 53 
also have roles in parasite gliding motility [5, 9-11] most likely by tethering glideosome associated proteins 54 
that reside in the IMC. 55 
 The  alveolins identified in Plasmodium are characterised by having one or more highly conserved 56 
domains separated by regions of variable length and amino acid composition. These conserved ‘alveolin’ 57 
domains are composed of tandem repeat sequences [7, 12]. This has revealed an interesting parallel with 58 
metazoan intermediate filament proteins such as lamins and keratins, whose underlying architectures 59 
include a helical rod domain that can form coiled-coils by virtue of a seven amino acid tandem repeat 60 
structure [13]. These coiled-coil domains are thought to be fundamental for the filament-forming properties 61 
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of these molecules. Apart from the conserved alveolin domains, a subset of the alveolins also possess 62 
conserved cysteine motifs close to their amino- or carboxy-terminus (Fig. 1). These motifs are made up of a 63 
single cysteine and a double cysteine that are separated by a small number of other amino acids (Fig. 1). 64 
With the exception of IMC1i, The N- and C-terminal motifs are inverted, with the single cysteine located 65 
nearest the end of the polypeptide (Fig. 1). The function of these cysteine motifs is largely unknown, 66 
although they have been suggested to provide sites for post-translational S-palmitoylation [14] (Fig. 1). A 67 
subset of alveolins in Toxoplasma (IMC1, IMC4, IMC14 and IMC15) possess similar conserved terminal 68 
cysteine motifs [14]. Because these conserved cysteine motifs have not been identified in alveolins from 69 
dinoflagellates or ciliates, their function could be related to the unique motility and/or cytokinesis 70 
associated with the Apicomplexa [6]. IMC1a is the only Plasmodium alveolin with conserved cysteine 71 
motifs at both ends, and in this study we employ site-directed mutagenesis and allelic replacement in P. 72 
berghei to investigate the contribution of these motifs to the function of the protein and the SPN as a whole. 73 
We also describe a new method for accurate size measurements of sporozoite populations, providing a 74 
valuable new tool for assessing sporozoite phenotypes. 75 
 76 
 77 
  78 
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2. Materials and Methods 79 
2.1 Animal use  80 
All laboratory animal work is subject to regular ethical review by the London School of Hygiene and 81 
Tropical Medicine, and has approval from the United Kingdom Home Office. Work was carried out in 82 
accordance with the United Kingdom Animals (Scientific Procedures) Act 1986 implementing European 83 
Directive 2010/63 for the protection of animals used for experimental purposes. Experiments were 84 
conducted in 6-8 weeks old female CD1 mice, specific pathogen free and maintained in filter cages. Animal 85 
welfare was assessed daily and animals were humanely killed upon reaching experimental or humane 86 
endpoints. Mice were infected with parasites by intraperitoneal injection, or by infected mosquito bite on 87 
anaesthetized animals. Parasitemia was monitored regularly by collecting of a small drop of blood from a 88 
superficial tail vein. Drugs were administered by intraperitoneal injection or where possible were supplied 89 
in drinking water. Parasitized blood was harvested by cardiac bleed under general anaesthesia without 90 
recovery.  91 
 92 
2.2 Parasite maintenance, transmission, culture and purification 93 
P. berghei ANKA clone 2.34 parasites were maintained as cryopreserved stabilates or by mechanical blood 94 
passage and regular mosquito transmission. Mosquito infection and transmission assays were as previously 95 
described using Anopheles stephensi [5, 15] and infected insects were maintained at 20°C at approximately 96 
70% relative humidity. 97 
 98 
2.3 Construction of gene targeting vectors 99 
To allow mCherry tagging of IMC1a, an approximately 3.5kb fragment corresponding to the entire imc1a 100 
gene (introns included) plus 5’-UTR was PCR amplified from P. berghei gDNA using primers pDNR-101 
imc1a-F (ACGAAGTTATCAGTCGAGGTACCTTTCATGATTCTATCTATTGTTAATTTTAATTG) and 102 
pDNR-imc1a-R (ATGAGGGCCCCTAAGCTTTTATCTTGATTACAAAAATAATTACAACATTTG) 103 
and introduced into SalI/HindIII-digested pDNR-mCherry [16] by in-fusion to give plasmid pDNR-104 
IMC1a/mCherry (Fig. S1).  105 
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 To substitute the N-terminal cysteine motif of IMC1a (Mutant 1) primers IMC1a-Mut1-F 106 
(GAAAATAAATAGTAATCTCGAGCATGATGAGTTGGGAGAAGACA) and IMC1a-Mut1-R 107 
(ATTACTATTTATTTTCCATGCATCAAACATTTTAATTAAATG) were used to PCR amplify  pDNR-108 
IMC1a/mCherry, and the PCR product was circularized by in-fusion to give plasmid pDNR-IMC1a-Mutant 109 
1. Introduction of  a diagnostic XhoI site changes the double cysteine (CC) in the amino-terminal motif to 110 
leucine-glutamate (LE). To substitute the C-terminal cysteine motif of IMC1a (Mutant 2) primers IMC1a-111 
Mut2-F (CTCGAGAATTATTTTTGGAATCAAGATAAAAGCTTAGGGGC) and IMC1a-Mut2-R 112 
(CCAAAAATAATTCTCGAGTTTGTCTTCAGAATTATCACTTTTTTTT) were used to PCR amplify  113 
pDNR-IMC1a/mCherry, and the PCR product was circularized by in-fusion to give plasmid pDNR-IMC1a-114 
Mutant 2. Introduction of a diagnostic XhoI site changes the double cysteine (CC) in the carboxy-terminal 115 
motif to leucine-glutamate (LE). To substitute the double cysteine from the C-terminal cysteine motif of 116 
IMC1a (Mutant 3) primers IMC1a-Mut3-F 117 
(CTCGAGAATTATTTTTGTAATCAAGATAAAAGCTTAGGGGC) and IMC1a-Mut3-R 118 
(ACAAAAATAATTCTCGAGTTTGTCTTCAGAATTATCACTTTTTTTT) were used to PCR amplify  119 
pDNR-IMC1a/mCherry, and the PCR product was circularized by in-fusion to give plasmid pDNR-IMC1a-120 
Mutant 3. This mutation introduces a diagnostic XhoI restriction site, changing the double cysteine (CC) in 121 
the carboxy-terminal motif to leucine-glutamate (LE). To substitute the single cysteine from the C-terminal 122 
cysteine motif of IMC1a (Mutant 4) primers IMC1a-Mut4-F 123 
(TTATTTCGCGAATCAAGATAAAAGCTTAGGGGC) and IMC1a-Mut4-R 124 
(TTGATTCGCGAAATAATTACAACATTTGTCTTCAGAATTATCACT) were used to PCR amplify  125 
pDNR-IMC1a/mCherry, and the PCR product was circularized by in-fusion to give plasmid pDNR-IMC1a-126 
Mutant 4. This mutation introduces a diagnostic NruI restriction site, changing the single cysteine (C) in the 127 
carboxy-terminal motif to alanine (A) (Fig. S1). 128 
 Primers hDHFR/ERI-F (ACAAAGAATTCATGGTTGGTTCGCTAAACT) and hDHFR/ERI-R 129 
(ACCATGAATTCTTTGTAACATTTAGGTGTGTATTTATATATATAAGC) were used to PCR amplify 130 
plasmid pLP-hDHFR  [17]. Template plasmid DNA was removed after the PCR by DpnI digestion, and the 131 
PCR product was circularized by in-fusion, to give plasmid pLP-hDHFR/EcoRI. In this plasmid the BamHI 132 
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restriction site site at beginning of the hDHFR gene is replaced with an EcoRI recognition sequence. A 1.7 133 
kb fragment corresponding to the hdhfryfcu gene was PCR amplified from plasmid pL0035 with primers 134 
hDHFRyFCU-F (ATGTTACAAAGAATTCATGGTTGGTTCGCTAAACTG) and hDHFRyFCU-R 135 
(AAGAAAAACGGGATCCTTAAACACAGTAGTATCTGTCACCAAAG) and introduced into 136 
EcoRI/BamHI-digested pLP-hDHFR/EcoRI by in-fusion to give pLP-hDHFRyFCU. A 0.75 kb fragment 137 
corresponding to the 3’UTR of the imc1a gene was amplified from P. berghei gDNA with primers pLP-138 
imc1a-F (ATATGCTAGAGCGGCCAAAATATGGTATTTTAAAACTATTGAATTGG) and pLP-imc1a-139 
R (CACCGCGGTGGCGGCCAGCGACACTTAAGAGATAGCATAAGA) and introduced into NotI-140 
digested pLP-hDHFRyFCU by in-fusion to give plasmid pLP-hDHFRyFCU/IMC1a.   141 
 Cre-loxp recombination of pDNR-IMC1a/mCherry, pDNR-IMC1a-Mutant 1 and pDNR-IMC1a-142 
Mutant 2, pDNR-IMC1a-Mutant 3 and pDNR-IMC1a-Mutant 4 was carried out with pLP-143 
hDHFRyFCU/IMC1a to give the final targeting vectors pLP-IMC1a/mCherry-WT, pLP-IMC1a/mCherry-144 
Mutant 1 to pLP-IMC1a/mCherry-Mutant 4, respectively.  145 
 Sequence verification across the IMC1a::mCherry-encoding region identified one targeting vector 146 
that had obtained an undesired frameshift close to the 5'-end of the imc1a coding sequence. This plasmid 147 
was used to generate a new IMC1a null mutant parasite (IMC1a/mCherry-KO) by the same targeting 148 
strategy as the other parasite lines.  149 
 150 
2.4 Generation and genomic analysis of genetically modified parasites 151 
Parasite transfection, pyrimethamine selection and dilution cloning were performed as previously described 152 
[18]. The imc1a gene targeting strategy employed double crossover homologous recombination, ensuring 153 
that its modifications were stable and non-reversible (Fig. S1). Prior to performing transfections, plasmid 154 
DNA was double-digested with KpnI and SacII to remove the plasmid backbone. Genomic DNA extraction 155 
was performed as previously described [15]. After transfection, drug resistant parasites were subjected to 156 
limiting dilution cloning. Integration of the selectable marker gene into the imc1a locus was confirmed by 157 
diagnostic PCR across the 3' integration site using primers P3 158 
(ACAAAGAATTCATGGTTGGTTCGCTAAAC) and P4 (TGCACACCCACCTGATTG) (Fig. S1). 159 
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Integration of the mCherry-tagged IMC1a-encoding sequence into the imc1a locus was confirmed by 160 
diagnostic PCR across the 5' integration site with primers P1 (GCACATTAATGCATTTGGG) and P2 161 
(AACGGGATCTTCTAGTTACTTGTACAGCTCGTCCATGC) (Fig. S1). The absence of the unmodified 162 
imc1a allele in the clonal parasite lines was confirmed by diagnostic PCR with primers P1 and P4 (Fig. S1). 163 
 164 
2.5 Sporozoite footprint measurements 165 
Sporozoite-infected tissues were dissected from parasite-infected mosquitoes and the sporozoites gently 166 
released in a Dounce homogenizer. Sporozoites were spotted onto glass microscope slides, allowed to 167 
adhere and then air dried. After methanol fixation, Giemsa-stained images of individual cells were captured 168 
by microscopy on Zeiss LSM510 inverted laser scanning confocal microscope. Using Zeiss LSM image 169 
browser software the circumference was measured, and the surface area occupied (i.e. the footprint) 170 
calculated. Statistical analysis was carried out using two-tailed t-test. 171 
 172 
2.6 Western blot analysis 173 
Parasite samples were heated directly in SDS-PAGE loading buffer at 70ºC for 10 min. Proteins were 174 
fractionated by electrophoresis through NuPage 4-12% Bis-Tris precast gels (Invitrogen) and transferred to 175 
PVDF membrane (Invitrogen) according to the manufacturer’s instructions. Membranes were blocked for 176 
non-specific binding in PBS supplemented with 0.1% Tween 20 and 5% skimmed milk for 1h at room 177 
temperature. Rabbit polyclonal antibody against RFP (Abcam) diluted 1 in 5,000 was applied to the 178 
membrane for 1h at room temperature. After washing, membranes were incubated with goat anti rabbit IgG 179 
conjugated to horse radish peroxidase (HRP) (Abcam) diluted 1 in 5,000 for 1h at room temperature. After 180 
further washing, signal was detected by chemiluminescence (ECL western blotting substrate, Pierce) 181 
according to manufacturer’s instructions. For reprobing, the blot was incubated in 30% hydrogen peroxide 182 
solution for 30min at 37 degrees to inactivate residual HRP [19]. The membrane was reblocked and then 183 
incubated with monoclonal antibody 3D11 against circumzoite protein (CSP) diluted 1 in 1000 for 1h at 184 
room temperature. After washing secondary goat-anti-mouse polyclonal antibody conjugated to HRP 185 
 9 
(Invitrogen 81-6520) diluted 1 in 5000 was added and incubated for 1h at room temperature prior to 186 
washing and chemilluminescence detection.  187 
 188 
2.7 RT-PCR analysis 189 
Twenty midguts were harvested from parasite-infected mosquitoes at two weeks post-infection, pooled, and 190 
total RNA was extracted using a Qiagen RNeasy mini kit according to manufacturer's instructions. First 191 
strand cDNA was synthesized with M-MLV reverse transcriptase, (RNase H minus point mutation; 192 
Promega) using oligo(dT)25 as primer, for 1h at 50°C. Excess primer was removed by column purification 193 
(Qiaquick gel extraction kit; Qiagen) and the eluted cDNA was subjected to PCR amplification with 194 
primers A30 (ATATAGTCCATTTAGTTAGAGTTTGTG) and pDNR-imc1a-R 195 
(ATGAGGGCCCCTAAGCTTTTATCTTGATTACAAAAATAATTACAACATTTG) 196 
to amplify imc1a, and primers tub1-F (GAAGTAATAAGTATACATGTAGG) and tub1-R 197 
(ACACATCAATGACTTCTTTACC) to amplify tubulin 1. 198 
 199 
2.8 Microscopy 200 
For assessment of fluorescence, live parasite samples were assessed, and images captured, on a Zeiss 201 
LSM510 inverted confocal microscope and Zeiss LSM image browser software. For comparison of samples, 202 
images were captured with the same settings using the 'reuse' function. 203 
 204 
  205 
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3. Results 206 
3.1 The terminal cysteine motifs of IMC1a affect protein stability 207 
To study expression and localization of IMC1a and variants of it in the parasite, we first generated a 208 
transgenic P. berghei line that expresses full-length IMC1a fused to a carboxy-terminal mCherry tag (Fig. 209 
S1), named IMC1a/mCherry-WT. To study the contribution of the cysteine motifs to IMC1a function, 210 
mutations substituting the three cysteines were introduced by site-directed mutagenesis removing either the 211 
N-terminal motif (named IMC1a/mCherry-Mutant 1) or the C-terminal motif (named IMC1a/mCherry-212 
Mutant 2) (Fig. S1). The mutations introduced a diagnostic XhoI restriction site in order to screen targeting 213 
vectors and transgenic parasites for the presence of the desired mutation. Introduction of this XhoI site 214 
changes the double cysteine (CC) to a leucine-glutamate (LE) (Fig. S1). In addition, an IMC1a/mCherry 215 
targeting vector that contained a frame shift very near the 5' end of the coding sequence was used to 216 
generate a new IMC1a null mutant parasite line (named IMC1a/mCherry-KO) using the same genetic 217 
approach as the other IMC1a lines (Fig. S1).  218 
 Parasite line IMC1a/mCherry-WT developed normally in mouse and mosquito, and was readily 219 
transmitted by sporozoite-infected mosquito bite, demonstrating that the mCherry tag did not interfere with 220 
normal IMC1a function. Using fluorescence microscopy, strong mCherry-based fluorescence was detected 221 
in sporulating oocysts (Fig. 2A). In both midgut and salivary gland sporozoites, the fluorescence was 222 
concentrated at the cell periphery (Fig. 2A) consistent with the location of the SPN. Western blot analysis 223 
of sporozoite lysates using anti-mCherry antibodies detected one major band migrating at approximately 224 
130kDa, corresponding to the IMC1a::mCherry fusion protein (Fig. 2B). Some smaller proteins of much 225 
lower intensity were also detected probably resulting from low level proteolytic processing/degradation. As 226 
expected, IMC1a/mCherry-KO parasites did not exhibit mCherry fluorescence in oocysts or sporozoites 227 
(Fig. 2C), because the mCherry tag is not expressed due to an upstream frameshift. IMC1a/mCherry-KO 228 
oocysts displayed a phenotype comparable to that previously described for IMC1a null mutants [5], 229 
producing numbers of sporozoites similar to its WT counterpart (mean midgut oocysts/sporozoites per 230 
mosquito IMC1a/mCherry-WT: 43/15,000; IMC1a/mCherry-KO: 52/17,000; n=10), but with abnormal size 231 
and shape (Fig. 2C).  232 
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 Parasite lines IMC1a/mCherry-Mutant 1 and Mutant 2 also displayed mCherry-based fluorescence 233 
in mature oocysts and sporozoites (Figs. 2DE), as expected, demonstrating that the full-length IMC1a 234 
protein was expressed. However, in both mutants the fluorescence levels were markedly lower compared to 235 
parasite line IMC1a/mCherry-WT (Fig. 2A). These observations indicated that the removal of the amino- or 236 
carboxy-terminal cysteine motif from IMC1a had adversely affected either the amount of the alveolin in the 237 
parasite, or the ability of its mCherry moiety to fluoresce. To distinguish between these possibilities, we 238 
quantified the amounts of IMC1a in sporozoite samples of the different parasite lines by western blot 239 
analysis. The values obtained revealed that, relative to circumsporozoite protein (CSP), significantly 240 
reduced amounts of IMC1a::mCherry fusion protein were present in Mutant 1 and Mutant 2 (on average 241 
10% and 21% of WT levels, respectively; P<0.001; n=3) (Fig. 3A). These reduced levels of 242 
IMC1a::mCherry fusion protein in the parasite explain the lower fluorescence levels observed in Mutant 1 243 
and Mutant 2. Sporozoites of IMC1a/mCherry-Mutant 1 had consistently lower levels of IMC1a than 244 
Mutant 2, although the differences were not statistically significant (P=0.09).  245 
 Because all the transgenic parasite lines used in this study were generated with the same gene 246 
targeting strategy, and express IMC1a from the same, native imc1a promoter (Fig. S1), imc1a gene 247 
expression at the transcription level should not be affected. To confirm this, we carried out reverse 248 
transcription-PCR analysis on sporulating oocysts. This was done with Mutant 1 - which showed the lowest 249 
IMC1a protein level - in direct comparison with the control parasite line IMC1a/mCherry-WT, and 250 
normalised against the reference tubulin 1 gene (tub1). Primers for imc1a amplified a mRNA-specific 2.4kb 251 
product, and a gDNA-specific 2.8kb product (due to introns), while primers for tub1 mainly amplified a 252 
mRNA-specific 0.35kb product (the product amplified from gDNA is 1.0kb due to introns [7]) (Fig. 3B). 253 
Measured band intensities normalised against the reference tub1 gene showed that IMC1a/mCherry-Mutant 254 
1 oocysts contained approximately 1.5-fold more imc1a mRNA than its WT counterpart. Accordingly, the 255 
reduced levels of IMC1a present in Mutant 1, and by analogy in Mutant 2, are unlikely to be caused by a 256 
reduced imc1a gene expression at the transcription level.  257 
 258 
3.2 The terminal cysteine motifs of IMC1a affect sporozoite shape 259 
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Microscopic examination of sporozoites from IMC1a/mCherry-Mutant 1 and Mutant 2 indicated that they 260 
had an abnormal shape (Fig. 2). Although this shape was reminiscent of the shape of IMC1a null mutant 261 
sporozoites, it appeared less severe than is the case after a complete knockout of IMC1a expression (Fig. 262 
2C). Because of the variable and irregular shapes of the mutant sporozoites, their size was difficult to define 263 
by linear measurements of length and width. Thus, we developed a more sensitive measure of the observed 264 
changes in sporozoite morphology by determining their 'footprint', which gives a quantitative measure of 265 
the sporozoite's size independent of its shape. Footprint data were collected by measuring the surface area 266 
occupied by Giemsa-stained sporozoites dried onto microscope slides, and showed that KO sporozoites 267 
were on average significantly smaller than WT sporozoites (P<0.0001, n=27), in fact less than half the 268 
normal size (Fig. 3C). Sporozoites of Mutant 1 and Mutant 2 had intermediate sizes, both being 269 
significantly smaller that WT sporozoites (P<0.0001, n=27), but significantly larger than KO sporozoites 270 
(P<0.0001, n=27) (Fig. 4C). Mutant 1 sporozoites were on average smaller than those of Mutant 2, albeit 271 
the differences were not statistically significant (P=0.07, n=27) (Fig. 3C). These observations demonstrate 272 
that mutations of the terminal cysteine motifs of IMC1a cause intermediate phenotypes with regards to 273 
sporozoite shape and size, compared to null mutants. We did not observe discernible shape/size differences 274 
between midgut- and salivary gland-derived sporozoite populations within our mutant lines (data not shown, 275 
and Fig. S2), pointing to similar infectivity levels throughout the population irrespective of sporozoite 276 
size/shape. 277 
 278 
3.3 The terminal cysteine motifs of IMC1a affect sporozoite infectivity 279 
We analyzed the effects of the cysteine mutations on sporozoite infectivity by infecting Anopheles 280 
stephensi vector mosquitoes. The reference parasite line IMC1a/mCherry-WT gave rise to high numbers of 281 
salivary gland sporozoites (Table 1) that were readily transmissible by mosquito bite. In sharp contrast, our 282 
IMC1a null mutant sporozoites were unable to reach the salivary glands in detectable numbers (Table 1) in 283 
full agreement with a previous study [5]. Salivary gland sporozoite numbers for Mutant 2 were consistently 284 
lower (3- to 4-fold) than those observed for IMC1a/mCherry-WT parasites (Table 1), pointing to a reduced 285 
infectivity to the salivary glands. Nonetheless, Mutant 2 sporozoites could be transmitted to mice by 286 
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mosquito bite, and after transmission the phenotype of Mutant 2 remained unchanged with respect to 287 
fluorescence level, sporozoite size and infectivity (data not shown). In contrast to Mutant 2, salivary gland 288 
sporozoite numbers for Mutant 1 were markedly reduced (>10-fold) (Table 1), and we were repeatedly 289 
(n=5) unable to transmit this parasite by mosquito bite. The lack of mosquito transmission of Mutant 1 290 
could be caused by the low numbers of salivary gland sporozoites, or by a reduced sporozoite infectivity to 291 
the mouse, or a combination of both. Because of the low numbers of salivary gland sporozoites that could 292 
be obtained from Mutant 1-infected mosquitoes, sporozoite infectivity to the mouse by needle injection was 293 
not assessed. Nonetheless, the combined results demonstrate that IMC1a/mCherry-Mutant 1 and Mutant 2 294 
possess intermediate phenotypes with regards to sporozoite infectivity. These infectivity data are consistent 295 
with and supported by the other phenotypes reported in this paper (IMC1a expression level, sporozoite 296 
shape and size). 297 
 298 
3.4 Properties of the carboxy-terminal cysteine motif are determined by the di-cysteine  299 
In contrast to the N-terminal cysteine motif of IMC1a, where all three cysteine residues are predicted to be 300 
palmitoylated (Fig. 1), within the C-terminal cysteine motif the di-cysteine, but not the single cysteine, are 301 
predicted to be palmitoylated (Fig. 1). If this prediction is accurate and palmitoylation were indeed key to 302 
the role of the terminal cysteine motifs, then substitution of the single cysteine of the C-terminal motif 303 
should have little effect on IMC1a stability and function, while substitution of the di-cysteine should 304 
resemble the Mutant 2 phenotype. To test this hypothesis, we generated two more mutants of the carboxy-305 
terminal cysteine motif in IMC1a, in which either its di-cysteine (named IMC1a/mCherry-Mutant 3) or its 306 
single cysteine (named IMC1a/mCherry-Mutant 4) were substituted (Fig. S1). Subsequent phenotypic 307 
assessment revealed that Mutant 4 parasites were indistinguishable from their WT counterparts displaying 308 
bright fluorescence that was concentrated at the cortex of normal shaped sporozoites (Fig. 4B). By contrast, 309 
Mutant 3 oocysts and sporozoites displayed markedly lower fluorescence levels (Fig. 4A) and were 310 
indistinguishable from those of Mutant 2. Footprint measurements confirmed that the average size of 311 
Mutant 4 sporozoites was similar to that of IMC1a/mCherry-WT sporozoites (P=0.99, n=27) (Fig. 4C), 312 
while Mutant 3 sporozoites were indistinguishable from those of IMC1a/mCherry-Mutant 2 in terms of 313 
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shape and size (P=0.38, n=27) (Fig. 4C). In terms of infectivity, too, Mutant 4 resembled its WT 314 
counterpart, while Mutant 3 behaved like Mutant 2 (Table 1). These data show that the double cysteine 315 
(CC) contributes primarily to the properties of the carboxy-terminal cysteine motif, as evidenced by the 316 
same wildtype phenotypes of the IMC1a/mCherry-WT (CC...C) and Mutant 4 (CC...A) parasite lines, as 317 
well as the same intermediate phenotypes of the IMC1a/mCherry-Mutant 3 (LE...C) and Mutant 2 (LE...W) 318 
parasite lines. These data are consistent with the hypothesis that the di-cysteine is most likely a 319 
palmitoylation site, as predicted (Fig. 1). Moreover, the single cysteine within the same motif is not 320 
required for this lipid modification to occur. 321 
  322 
  323 
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4. Discussion 324 
In this study we have employed red fluorescent protein tagging in transgenic P. berghei parasites to study 325 
the function of the terminal cysteine residues of the alveolin IMC1a. The results obtained confirm the 326 
subcellular localisation and expression of IMC1a in the SPN of sporozoites, and show that mutagenesis of 327 
its conserved terminal cysteine motifs results in decreased protein stability causing markedly reduced levels 328 
of IMC1a protein, but not imc1a transcript, in the parasite. This, in turn, affects sporozoite shape, size and 329 
infectivity. We did not observe sporozoites with high (WT) levels of fluorescence in our mutant sporozoite 330 
populations. Assuming that IMC1a expression was not affected by the cysteine mutations, this suggests that 331 
the reductions in IMC1a levels occurred soon after translation and possibly before IMC1a recruitment to 332 
the pellicle.   333 
 One possible explanation for the alveolin instability is that the removal of cysteines in the mutant 334 
proteins has changed their ability to form specific sulphur bridges, leading to a degree of misfolding and 335 
degradation. Arguing strongly against this concept, however, is the localisation of IMC1a in the cytoplasm, 336 
a reducing environment that disfavours formation of intra- or intermolecular sulphur bridges [20]. A more 337 
likely explanation for the observed alveolin instability is that the removal of cysteine residues in IMC1a 338 
adversely affected the ability of this protein to be palmitoylated. S-palmitoylation is a post-translational 339 
thioester linkage of the 16-carbon fatty acid palmitate to cysteine residues that plays key roles in protein 340 
traffic, localisation, interaction and stability [21]. The conserved terminal cysteine motifs of the 341 
Plasmodium alveolins are predicted with high confidence to constitute palmitoylation sites (Fig. 1). 342 
Combined data from various Plasmodium proteomics studies reveal that at least six alveolins are detected 343 
in blood stage parasites [22-29]. Among these six only two, IMC1c and IMC1g, possess conserved terminal 344 
cysteine motifs (at the carboxy- and amino-terminus, respectively) (Fig. 1). Only IMC1c and IMC1g were 345 
detected in the P. falciparum blood stage palmitome [30], providing compelling experimental support for a 346 
link between these motifs and palmitoylation. Palmitoylation is known to affect protein stability [21], and 347 
indeed other known palmitoylated proteins associated with the parasite pellicle (e.g. PfGAP45 and 348 
PfMTIP) have been reported to become unstable and degraded when palmitoylation was interfered with 349 
using palmitoylation inhibitors or mutagenesis of palmitoylation sites [30]. Unfortunately, the relatively 350 
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small numbers of sporozoites that can be obtained from mosquitoes - a major impediment to biochemical 351 
analysis [31] - combined with the presence of a second palmitoylation site at the other end of the protein, 352 
and the highly reduced levels of IMC1a in Mutants 1 and 2, made it impossible to demonstrate that the 353 
terminal cysteine motifs of IMC1a are palmitoylation sites as predicted. Nonetheless, a molecular role for 354 
the terminal cysteine residues of IMC1a as substrates for palmitoylaton seems likely, and indeed is 355 
supported by our observation that mutagenesis of the C-terminal single cysteine residue, not predicted to be 356 
palmitoylated (Fig. 1), has no discernible effect on IMC1a stability and function (Fig. 4). Palmitoylation of 357 
alveolins is thought to promote their association with the IMC via lipid anchoring into the inner membrane 358 
[14]. Reductions in IMC1a palmitoylation caused by the cysteine mutations could adversely affect this 359 
process and/or protein folding or interaction, which in turn could result in instability and degradation [32]. 360 
 Gene disruption studies of different P. berghei alveolins have revealed very similar loss-of-function 361 
phenotypes adversely affecting morphology, motility and tensile strength [5, 8-11], indicating that alveolins 362 
contribute to the function of the SPN through a similar mechanism. While co-expressed alveolins make 363 
distinct contributions to SPN function in a given zoite, these differences appear to be mainly quantitative. 364 
For example, null mutants sporozoites of the alveolin IMC1h have an abnormal shape and reduced 365 
infectivity not dissimilar from IMC1a null mutants [10]. However, in contrast to the latter, IMC1h-KO 366 
sporozoites retain infectivity to the insect’s salivary glands [11]. Re-examination of the IMC1h-KO 367 
sporozoite size with the footprint method developed here shows that they are indeed significantly smaller 368 
(P<0.001) than their wildtype counterparts (parasite line IMC1h/GFP), but also significantly larger 369 
(P<0.0001) than IMC1a null mutant sporozoites (footprint IMC1h/GFP: 10.510.41 m2; IMC1h-KO: 370 
7.980.44 m2). These observations reveal a correlation between sporozoite size and infectivity, which is 371 
corroborated by the results of the current IMC1a study.  372 
 The intermediate phenotypes of IMC1a/mCherry-Mutant 1 and Mutant 2 with regards to sporozoite 373 
shape, size and infectivity (Figs. 2, 3, Table 1) indicate that the heavily depleted amount of IMC1a protein 374 
in their sporozoites remains at least partly functional, possibly because of a degree of functional redundancy 375 
between the amino- and carboxy-terminal cysteine motifs. The low levels of IMC1a::mCherry in these 376 
mutants did not allow a definitive allocation of the fusion protein in the sporozoite SPN by fluorescence 377 
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microscopy (Fig. 2). However, complete failure to localise to the functional site would be expected to result 378 
in a null mutant phenotype, which is clearly not the case. In further support for this notion, subcellular 379 
localisation of PfGAP45 lacking its palmitoylation site was shown to be unaffected, remaining at the IMC 380 
of developing merozoites [30]. Our Mutant 1 and Mutant 2 parasite lines are in effect IMC1a knockdowns, 381 
and combined with our observations that the severity of the phenotypes correlates well with the levels of 382 
IMC1a found in the parasite, this strongly indicates that IMC1a facilitates sporozoite morphogenesis and 383 
infectivity in a dose-dependent fashion. This demonstrates for the first time a link between the amount of 384 
alveolin in the zoite and its infectivity. Accordingly, SPN function in the cell would be governed not only 385 
by the repertoire of co-expressed alveolins, but also by the level of their expression. Fitting with the nature 386 
of structural proteins, this finding suggests that the relative abundance of an alveolin in the cell may 387 
determine its relative contribution to the cortical cytoskeleton. In support of this concept, it is perhaps not a 388 
coincidence that knockout of the ookinete-expressed alveolin IMC1d has no detectable phenotype, and also 389 
has the lowest expression level of all ookinete-expressed alveolins examined by us [7, 9, 10, 16]. Just a 390 
fraction of IMC1a (10%-21% of WT level in Mutant 1 and Mutant 2) is sufficient to partially restore the 391 
phenotype of IMC1a null mutant parasites (Fig. 4C, Table 1), which points to a non-linear correlation 392 
between alveolin level and phenotype, possibly due to the complexity of interactions with other alveolins 393 
and SPN components. The loss of infectivity of IMC1a null mutants is attributable to not just the reduced 394 
size and abnormal shape of the sporozoites, but also to accompanying reductions in motility (approximately 395 
5-fold) and tensile strength of the sporozoites [5]. By inference, the markedly reduced levels of IMC1a 396 
present in sporozoites of Mutant 1 and Mutant 2 (Fig. 3A) would result in reduced levels of motility and 397 
tensile strength, contributing to the observed losses in sporozoite infectivity in these parasite lines. Mutation 398 
of the N-terminal cysteine motif of IMC1a (Mutant 1) causes more severe phenotypes than substitution of 399 
the C-terminal cysteine motif (Mutant 2) with regards to IMC1a stability (Fig 3A) and infectivity to the 400 
salivary glands (Table 1). This difference could reflect quantitative differences in palmitoylation at the N- 401 
and C-terminus, as predicted (Fig. 1). Alternatively, the cysteine motifs may possess additional roles 402 
besides acting as palmitoylation sites, which could be different between the N- and C-terminus.  403 
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 TgIMC1, the T. gondii orthologue of Plasmodium IMC1a, contains similar N- and C-terminal 404 
terminal cysteine motifs [4, 5]. However, the C-terminal cysteine motif of TgIMC1 has several additional 405 
downstream cysteine residues and is not predicted to be palmitoylated with the method used here. Studies 406 
on TgIMC1 revealed a specific proteolytic cleavage near the carboxy-terminus of the protein upstream of 407 
its cysteine motif [33]. This cleavage coincides with the maturation of young parasites with a detergent-408 
labile SPN into mature parasites with a detergent-resistant SPN. Ablation of this cleavage through 409 
mutagenesis of certain cysteines prevented the SPN to mature and become detergent-resistant [33]. In the 410 
case of P. berghei IMC1a, there is little evidence for a similar cleavage event. Western analysis of our 411 
parasite lines expressing IMC1a fused to a carboxy-terminal mCherry tag shows that sporozoites contain 412 
predominantly full-length IMC1a::mcherry fusion product (Fig. 2B), and that if such a cleavage occurred in 413 
Plasmodium it would at best affect a very small proportion of the protein. It cannot be ruled out that the 414 
mCherry tag stopped the protease responsible from reaching the C-terminal cleavage site, preventing the 415 
IMC1a cleavage in our parasite lines. Arguing against this possibility, however, is the fact that mCherry 416 
tagging of IMC1a did not affect its subcellular localisation or cause a detectable phenotype, which indicates 417 
that IMC1a function was not affected. The apparent absence of this cleavage in IMC1a is more likely to 418 
reflect specific differences between Toxoplasma and Plasmodium. The formation of Plasmodium 419 
sporozoites within a protective oocyst capsule may have eliminated the need to develop within the 420 
protection of mechanically stable and rigid mother cell as is the case in Toxoplasma.  421 
 422 
  423 
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Figure legends 515 
 516 
Fig. 1 The Plasmodium alveolin cysteine motifs. A: Conserved cysteine motifs at the amino- and carboxy-517 
terminal ends of Plasmodium berghei alveolins IMC1a (PbANKA_0402600), IMC1c (PbANKA_1202000), 518 
IMC1g (PbANKA_1240600), IMC1i (PbANKA_0707100) and IMC1j (PbANKA_1120400). The number 519 
of non-cysteine residues (X) adjacent to the conserved terminal cysteines (C) are indicated. Cysteines in red 520 
are predicted to be palmitoylated. B: Prediction scores of palmitoylated cysteine residues (red) using CSS-521 
Palm 4.0 software (http://csspalm.biocuckoo.org/) and high threshold settings (95% specificity, 90% 522 
accuracy). 523 
 524 
Fig. 2 Phenotypic analyses of mCherry-tagged PbIMC1a parasite lines. A: Confocal fluorescence and 525 
brightfield images of a sporulating oocyst and sporozoite of parasite line IMC1a/mCherry-WT. B: Western 526 
blot of a sporozoite lysate of parasite line IMC1a/mCherry-WT (approximately 100,000 sporozoites loaded) 527 
using anti-mCherry antibodies, visualising the IMC1a::mCherry fusion protein. Size markers are shown on 528 
the left hand side. C-E: Confocal images of a sporulating oocyst and sporozoite of mutant parasite lines 529 
IMC1a/mCherry-KO (C); IMC1a/mCherry-Mutant 1 (D); IMC1a/mCherry-Mutant 2 (E). Confocal images 530 
were captured using the same confocal microscope settings. Scale bars represent 10m. 531 
 532 
Fig. 3 Cysteine mutations of IMC1a affect protein stability and sporozoite size. A: Western blot of 533 
sporozoite lysates from parasite lines IMC1a/mCherry-WT, Mutant 1 and Mutant 2, using anti-mCherry 534 
antibodies (top), or anti-CSP antibodies (bottom). B: Reverse transcription PCR analysis of imc1a mRNA 535 
levels (relative to tub1 mRNA) in sporulating oocysts of parasite lines IMC1a/mCherry-WT and Mutant 1. 536 
C: Representative Giemsa-stained sporozoite images from parasite lines IMC1a/mCherry-WT, KO, and 537 
Mutants 1-2. Numbers give meansem footprint measurements in m2 and numbers in brackets give 538 
footprint range in m2 (n=27). 539 
 540 
 24 
Fig. 4 The double cysteine contributes chiefly to the function of the cysteine motif. Confocal fluorescence 541 
and brightfield images of a sporulating oocyst and sporozoite of IMC1a/mCherry-Mutant 3 (A) and Mutant 542 
4 (B). Scale bars represent 10m. C: Representative Giemsa-stained sporozoite images of Mutants 3 and 4. 543 
Numbers give meansem footprint measurements in m2 and numbers in brackets give footprint range in 544 
m2 (n=27). 545 
  546 
 25 
Table 1 Effects of IMC1a mutations on Plasmodium berghei parasite development in 
Anopheles stephensi mosquitoes 
___________________________________________________________________________ 
Exp. Parasite line 
IMC1a/mCherry-  
Mean ± sem oocyst number 
per infected mosquito (n)
a
 
Mean salivary gland 
sporozoite number per 
infected mosquito
b
  
___________________________________________________________________________ 
1 WT 39  ± 7 (20)  10,900 
 KO 47 ± 8 (20) 0
 
 
    
2 WT  104 ± 42 (10) 6,600 
 Mutant 1  97 ± 32 (10) 110 
 Mutant 2  98 ± 27 (10) 2,800 
    
3 Mutant 1 94 ± 13 (20) 260 
 Mutant 2 133 ± 24 (20) 3,100 
    
4 WT  109 ± 31 (10) 4,900 
 Mutant 1  141 ± 50 (10) 220 
 Mutant 4  120 ± 44 (10) 5,600 
    
5 Mutant 2   34 ± 9 (20) 2,000 
 Mutant 3 36 ± 9 (20) 2,800 
    
6 WT 160 ± 33 (10) 16,600 
 Mutant 2 192 ± 30 (10) 3,900 
    
7 Mutant 1 47 ± 11 (10) 330 
 Mutant 4 78 ± 25 (10) 9,900 
___________________________________________________________________________ 
a
 n = Number of insects analysed. 547 
b
 The same insects were analysed for both oocyst and sporozoite numbers. Oocyst and sporozoite 548 
numbers are therefore directly linked, eliminating much of the variability associated with sample size. 549 
Oocyst counts were done on individual midguts, sporozoite counts were done on pooled salivary glands 550 
from n insects. 551 
 552 
 553 
 554 
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